Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 03 12:13PM ET
133.15
Dollar change
+0.83
Percentage change
0.63
%
IndexRUT P/E- EPS (ttm)-46.41 Insider Own3.71% Shs Outstand5.39M Perf Week4.31%
Market Cap720.34M Forward P/E15.28 EPS next Y8.72 Insider Trans-0.74% Shs Float5.21M Perf Month9.87%
Income-250.31M PEG- EPS next Q1.89 Inst Own90.68% Short Float3.12% Perf Quarter45.55%
Sales223.71M P/S3.22 EPS this Y-11.94% Inst Trans-1.50% Short Ratio4.80 Perf Half Y32.94%
Book/sh27.87 P/B4.78 EPS next Y5.53% ROA-46.23% Short Interest0.16M Perf Year37.42%
Cash/sh5.26 P/C25.30 EPS next 5Y- ROE-92.97% 52W Range82.86 - 141.17 Perf YTD27.09%
Dividend Est.0.64 (0.48%) P/FCF17.38 EPS past 5Y- ROI-86.43% 52W High-5.68% Beta0.85
Dividend TTM0.64 (0.48%) Quick Ratio1.37 Sales past 5Y16.61% Gross Margin53.15% 52W Low60.69% ATR (14)5.06
Dividend Ex-DateAug 30, 2024 Current Ratio1.94 EPS Y/Y TTM-13676.83% Oper. Margin4.66% RSI (14)60.19 Volatility3.31% 3.79%
Employees736 Debt/Eq0.97 Sales Y/Y TTM2.02% Profit Margin-111.89% Recom2.50 Target Price143.33
Option/ShortNo / Yes LT Debt/Eq0.92 EPS Q/Q711.15% Payout- Rel Volume0.78 Prev Close132.32
Sales Surprise4.37% EPS Surprise59.89% Sales Q/Q14.86% EarningsAug 05 BMO Avg Volume33.81K Price133.15
SMA206.48% SMA507.89% SMA20023.37% Trades Volume11,747 Change0.63%
Date Action Analyst Rating Change Price Target Change
Aug-28-24Initiated Wells Fargo Underweight $120
Jan-04-24Upgrade Evercore ISI In-line → Outperform $100 → $125
Jan-04-21Downgrade Evercore ISI Outperform → In-line $300
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $287
Oct-02-20Initiated JP Morgan Neutral $260
Dec-04-19Initiated Jefferies Buy
Aug-26-19Initiated Evercore ISI Outperform $250
Jun-10-16Downgrade Sidoti Buy → Neutral
Oct-02-24 02:00PM
Aug-26-24 12:20PM
12:00PM
Aug-16-24 07:51AM
Aug-05-24 08:15AM
08:00AM Loading…
08:00AM
Jul-31-24 09:14AM
Jul-08-24 02:00PM
Jun-05-24 11:53AM
06:38AM
06:21AM
06:00AM
May-31-24 06:00AM
May-22-24 06:00AM
Apr-08-24 08:00AM
06:24PM Loading…
Apr-04-24 06:24PM
Apr-01-24 10:27AM
Mar-15-24 07:00AM
Feb-19-24 10:23AM
Feb-05-24 09:20AM
08:36AM
08:22AM
08:00AM
Jan-08-24 08:00AM
Jan-04-24 03:00PM
Jan-03-24 08:00AM
Dec-14-23 10:47AM
Nov-06-23 09:10AM
08:13AM
08:00AM
03:00AM Loading…
Oct-16-23 03:00AM
Oct-03-23 08:00AM
Sep-22-23 08:09AM
06:20AM
Sep-15-23 01:10AM
Sep-13-23 01:37PM
Sep-11-23 11:21AM
Aug-24-23 04:02PM
Aug-10-23 01:32AM
Aug-03-23 09:35AM
08:27AM
08:00AM
Jul-31-23 07:50AM
Jul-05-23 03:00PM
Jun-21-23 08:00PM
11:50AM
May-25-23 09:25AM
08:14AM
08:00AM
May-22-23 01:16PM
May-02-23 06:23AM
Apr-26-23 08:00PM
Apr-03-23 06:15PM
06:00PM
07:42AM
Mar-13-23 08:00AM
Mar-09-23 08:00AM
Feb-21-23 05:36AM
Feb-14-23 09:00AM
Feb-13-23 12:45PM
08:00AM
Feb-06-23 09:55AM
08:36AM
Feb-01-23 12:43PM
06:43AM
Jan-27-23 06:00PM
Jan-19-23 06:15PM
Jan-17-23 04:33PM
Jan-13-23 06:00PM
Jan-12-23 09:40AM
Jan-11-23 06:26AM
Jan-09-23 06:15PM
Jan-03-23 05:00PM
Dec-28-22 06:51AM
05:20AM
Dec-18-22 04:48PM
Dec-16-22 11:59AM
Nov-23-22 12:20PM
Nov-17-22 08:04AM
Nov-08-22 06:48AM
Nov-04-22 03:49PM
Nov-03-22 10:25AM
08:00AM
Oct-25-22 06:32AM
Oct-03-22 02:00PM
Sep-11-22 08:33AM
Aug-04-22 11:05AM
08:00AM
Jul-28-22 10:03AM
Jul-06-22 07:00PM
Jun-27-22 08:01AM
May-31-22 09:25AM
08:00AM
May-13-22 10:17AM
Apr-12-22 09:51AM
Apr-06-22 01:10PM
Apr-04-22 12:02PM
Feb-03-22 09:25AM
09:11AM
08:00AM
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Archbold Brian DavidSVP OperationsSep 13 '24Sale125.001,499187,3750Sep 16 12:14 PM
Archbold Brian DavidOfficerSep 13 '24Proposed Sale125.001,499187,381Sep 13 04:35 PM
Sakys JohnCFOSep 01 '24Option Exercise0.001,037012,500Sep 06 12:46 PM
Owens Gary MPresident and CEOSep 01 '24Option Exercise0.003,301038,292Sep 06 12:21 PM
Archbold Brian DavidSVP OperationsSep 01 '24Option Exercise0.0084501,885Sep 06 12:12 PM
Sullivan John JamesDirectorSep 01 '24Option Exercise0.001,074027,878Sep 06 11:53 AM
Tripeny R TonyDirectorSep 01 '24Option Exercise0.001,07402,679Sep 06 11:43 AM
Ladiwala Shiraz ShabanaliDirectorSep 01 '24Option Exercise0.001,57403,074Sep 06 11:35 AM
Hall ShannonDirectorSep 01 '24Option Exercise0.001,07402,785Sep 06 11:28 AM
Alltoft Jennifer SadieDirectorSep 01 '24Option Exercise0.001,07403,474Sep 06 11:22 AM
Capone Mark ChristopherDirectorAug 15 '24Option Exercise0.007240724Aug 19 11:08 AM
Owens Gary MPresident and CEOJun 14 '24Option Exercise0.004,959034,991Jun 17 01:41 PM
Archbold Brian DavidSVP OperationsJun 14 '24Option Exercise0.0088901,447Jun 17 11:50 AM
Sakys JohnCFOJun 14 '24Option Exercise0.001,304012,035Jun 17 11:31 AM
Archbold Brian DavidSVP OperationsDec 15 '23Sale112.361,500168,540558Dec 19 11:21 AM